Sumitomo provides next-generation cancer therapeutics.

Sumitomo Pharma America (SMPA), is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need.

The company needed an exhibit that would provide an environment for oncologists to learn more about new therapies.

Solution

Sumitomo Pharma America, Inc. is engaged in the R&D, manufacturing, and sales of pharmaceuticals.

Sumitomo Pharma America, Inc. launched in July 2023 through consolidation of the functions and human resources of seven U.S. group companies: Sunovion Pharmaceuticals Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc., and Enzyvant Therapeutics, Inc.

Since Sumitomo Pharma’s goal is to promote its pipeline in a classic exhibit, flexibility, modularity, and reduced weight continue to be part of the solution. Creating a clearly defined space in which scientists can discuss their research with attendees was important. From the debut of the exhibit, Access has continued to add custom elements to standard wall patterns, allowing Sumitomo Pharma to control costs yet maintain a very consistent look.

nashville expo

The corporate green stands out on the show floor in a sea of blue and white. Sumitomo Pharma’s exhibit has become a destination for ASCO attendees.

phili exhibit

The uppermost layer of the structure is a large fabric hanging sign, providing heightened identity on the floor and defining the perimeter.

san francisco exhibit

A wood-grain vinyl floor completes the experience of stepping into a unique environment surrounded by so many other exhibits.

Exhibit Results

Oncologists have come to recognize the overhead structure as distinctly Sumitomo Pharma. Even when the company exhibits in smaller spaces, there is a distinct look and feel.

Through its strategic partnerships and investments from its parent company, Sumitomo Pharma continues to unveil new paths to innovative cancer treatments.

Explore the Exhibit